Save your place

Sign in to WhoBought

Please try again later.

MoonLake Immunotherapeutics (MLTX) institutional ownership

Latest close $20.06 Jul 21, 2026
Market cap$3.4B 52-week range SectorHealthcare
Funds holding · Q1 2026
149
reported MLTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
85 buyers · 64 sellers

MoonLake Immunotherapeutics (MLTX) price and institutional activity

Dates

Q1 2026

$0 bought by 85 investors
Mpm Bioimpact LLCDeep Track Capital, LP +83 more
$0 sold by 64 investors
Bvf IncJane Street Group, LLC +62 more
Bought Sold Totals per quarter; hover a bar for the names.

MoonLake Immunotherapeutics (MLTX) institutional activity · 149

Investor Type Est. change Change Δ Own Date
Bvf Inc · Reduced
Change −3.8M Date Q1 2026
Bvf Inc Reduced· Q1 2026 −3.8M Q1 2026
Mpm Bioimpact LLC · New
Change +1.8M Date Q1 2026
Mpm Bioimpact LLC New· Q1 2026 +1.8M Q1 2026
Deep Track Capital, LP · Added
Change +1.8M Date Q1 2026
Deep Track Capital, LP Added· Q1 2026 +1.8M Q1 2026
Weiss Asset Management LP · Added
Change +1.4M Date Q1 2026
Weiss Asset Management LP Added· Q1 2026 +1.4M Q1 2026
Janus Henderson Group PLC · Added
Change +1.4M Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +1.4M Q1 2026
Jane Street Group, LLC · Reduced
Change −1.2M Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −1.2M Q1 2026
Citadel Advisors LLC Added· Q1 2026 +943K +247.5% Q1 2026
Goldman Sachs Group Inc · Added
Change +860K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +860K Q1 2026
BlackRock · Added
Change +735K Date Q1 2026
BlackRock Added· Q1 2026 +735K Q1 2026
Bank of America Corp · Added
Change +711K Date Q1 2026
Bank of America Corp Added· Q1 2026 +711K Q1 2026
Candriam S.c.a. · Added
Change +684K Date Q1 2026
Candriam S.c.a. Added· Q1 2026 +684K Q1 2026
Nuveen, LLC · Reduced
Change −604K Date Q1 2026
Nuveen, LLC Reduced· Q1 2026 −604K Q1 2026
Holocene Advisors, LP · New
Change +600K Date Q1 2026
Holocene Advisors, LP New· Q1 2026 +600K Q1 2026
Point72 Asset Management, L.P. · Added
Change +596K Δ Own +77.2% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +596K +77.2% Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −505K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −505K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 149

Famous investor activity in MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Reich Kristian · Officer Sell −$878K
Price $20.09 Qty −44K Owned 2.8M ΔOwn −1.6% Trade date Jul 20, 2026 Filed date Jul 21, 2026
Reich Kristian Officer Sell $20.09 −44K −$878K 2.8M −1.6% Jul 20, 2026 Jul 21, 2026
Reich Kristian · Officer Sell −$322K
Price $20.01 Qty −16K Owned 2.8M ΔOwn −0.6% Trade date Jul 15, 2026 Filed date Jul 20, 2026
Reich Kristian Officer Sell $20.01 −16K −$322K 2.8M −0.6% Jul 15, 2026 Jul 20, 2026
Santos da Silva Jorge · Director Sell −$1.4M
Price $20.02 Qty −68K Owned 2.8M ΔOwn −2.4% Trade date Jul 10, 2026 Filed date Jul 13, 2026
Santos da Silva Jorge Director Sell $20.02 −68K −$1.4M 2.8M −2.4% Jul 10, 2026 Jul 13, 2026
Santos da Silva Jorge · Director Sell −$679K
Price $20.01 Qty −34K Owned 2.8M ΔOwn −1.2% Trade date Jul 9, 2026 Filed date Jul 13, 2026
Santos da Silva Jorge Director Sell $20.01 −34K −$679K 2.8M −1.2% Jul 9, 2026 Jul 13, 2026
Santos da Silva Jorge · Director Sell −$957K
Price $20.03 Qty −48K Owned 2.9M ΔOwn −1.6% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Santos da Silva Jorge Director Sell $20.03 −48K −$957K 2.9M −1.6% Jul 1, 2026 Jul 2, 2026
Bodenstedt Matthias · Officer Sell −$862K
Price $22.04 Qty −39K Owned 1.1M ΔOwn −3.4% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Bodenstedt Matthias Officer Sell $22.04 −39K −$862K 1.1M −3.4% Jun 22, 2026 Jun 23, 2026
Bodenstedt Matthias · CFO Sell −$55K
Price $19.60 Qty −3K Owned 1.2M Trade date Jun 18, 2026 Filed date Jun 18, 2026
Bodenstedt Matthias CFO Sell $19.60 −3K −$55K 1.2M Jun 18, 2026 Jun 18, 2026
Bvf Partners L P · Director Grant (A) 22K
Owned 22K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Bvf Partners L P Director Grant (A) 22K 22K Jun 17, 2026 Jun 22, 2026
Bodenstedt Matthias · CFO Sell −$297K
Price $19.68 Qty −15K Owned 1.2M Trade date Jun 17, 2026 Filed date Jun 18, 2026
Bodenstedt Matthias CFO Sell $19.68 −15K −$297K 1.2M Jun 17, 2026 Jun 18, 2026
Phillips Andrew John · Director Grant (A) 22K
Owned 22K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Phillips Andrew John Director Grant (A) 22K 22K Jun 17, 2026 Jun 18, 2026
Loy Spike · Director Grant (A) 22K
Owned 22K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Loy Spike Director Grant (A) 22K 22K Jun 17, 2026 Jun 18, 2026
Moukheibir Catherine · Director Grant (A) 22K
Owned 22K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Moukheibir Catherine Director Grant (A) 22K 22K Jun 17, 2026 Jun 18, 2026
Xavier Ramnik · Director Grant (A) 22K
Owned 22K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Xavier Ramnik Director Grant (A) 22K 22K Jun 17, 2026 Jun 18, 2026
Reich Kristian · Officer Sell −$972K
Price $19.43 Qty −50K Owned 2.8M Trade date Jun 17, 2026 Filed date Jun 17, 2026
Reich Kristian Officer Sell $19.43 −50K −$972K 2.8M Jun 17, 2026 Jun 17, 2026
Reich Kristian · Officer Sell −$935K
Price $18.70 Qty −50K Owned 2.9M Trade date Jun 16, 2026 Filed date Jun 17, 2026
Reich Kristian Officer Sell $18.70 −50K −$935K 2.9M Jun 16, 2026 Jun 17, 2026
15 of 41
15 of 41 Sign in to continue to older insider transactions.

MoonLake Immunotherapeutics (MLTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Biotechnology Value Fund L P 10.2M
% of shares outstanding 16.3% Filing date Oct 8, 2024
Biotechnology Value Fund L P 10.2M 16.3% Oct 8, 2024
Chen Bihua 8.5M
% of shares outstanding 14.2% Filing date Feb 14, 2024
Chen Bihua 8.5M 14.2% Feb 14, 2024
FMR LLC 4.9M
% of shares outstanding 7.9% Filing date Nov 12, 2024
FMR LLC 4.9M 7.9% Nov 12, 2024
Cormorant Asset Management, LP 4.5M
% of shares outstanding 6.2% Filing date May 15, 2026
Cormorant Asset Management, LP 4.5M 6.2% May 15, 2026
BlackRock Inc. 742K
% of shares outstanding 6.2% Filing date Feb 3, 2022
BlackRock Inc. 742K 6.2% Feb 3, 2022
Merck Healthcare Kgaa 27.9M
% of shares outstanding 4.7% Filing date Feb 15, 2024
Merck Healthcare Kgaa 27.9M 4.7% Feb 15, 2024
Citadel Advisors LLC 2.0M
% of shares outstanding 3.3% Filing date Feb 14, 2024
Citadel Advisors LLC 2.0M 3.3% Feb 14, 2024
T. Rowe Price Associates 823K
% of shares outstanding 2.1% Filing date Feb 14, 2023
T. Rowe Price Associates 823K 2.1% Feb 14, 2023
8 of 10

MoonLake Immunotherapeutics (MLTX) ownership FAQ

Who owns MLTX?

149 reporting institutions disclosed MLTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.